Industry committee  I think I would describe it, rather than as a chain, more as a network. In the case of access to medicines, it clearly has to be there, but whether sourced through patented drugs or through generics, there are multiple ways of getting access to medicines at affordable prices, and

Industry committee  Thank you, Mr. Sweet. I'd like to thank you for the opportunity to address the committee today. I'm the managing director of the UBC technology transfer office. I have about 20 years of experience in patenting and licensing university technologies, much of that in the biopharma

Industry committee  That's as close as it comes. At the outset, I'd like to acknowledge that I'm not speaking to you on behalf of the University of British Columbia but rather as a member of the university community, and the views expressed are my own. I'm very proud to say that in 2007, UBC was